Advertisement

Topic - Semaglutide

Related Stories

This photo shows Novo Nordisk headquarters in Bagsvaerd, Denmark, on Feb. 5, 2025. (Mads Claus Rasmussen/Ritzau Scanpix via AP, File)

Novo Nordisk sues telehealth company Hims & Hers over its GLP-1 weight loss drugs

By Brad Matthews - The Washington Times

Boxes for the medications Wegovy and Zepbound are arranged for a photograph in California on May 8, 2025. (AP Photo/JoNel Aleccia, File)

Compounded alternatives to Ozempic, Wegovy disallowed by FDA

By Brad Matthews - The Washington Times

FILE - A woman holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File)

Could obesity drugs help with alcohol cravings? New study suggests potential

By Carla K. Johnson - Associated Press

FDA warns consumers not to use off-brand versions of Ozempic, Wegovy

By Jonel Aleccia - Associated Press

This combination of photos provided by Matthew Barlow shows him in November 2022, left, and April 2023 in California. Barlow, a 48-year-old health technology executive, said he has lost more than 100 pounds since November by using the drug Mounjaro and changing his diet. (Courtesy Matthew Barlow via AP)

Powerful new obesity drug poised to upend weight loss care

By Jonel Aleccia - Associated Press